This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Scohia Pharma, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovator Profile: Ryoma Hara
Introduction: Ryoma Hara, based in Kanagawa, Japan, is an accomplished inventor with a focus on creating impactful solutions in the field of medicine. He holds a notable patent that addresses critical health issues, showcasing his dedication to improving human health and well-being.
Latest Patents: Ryoma Hara has been granted a patent for a macrocyclic compound, which possesses NRF2 activating activity. This compound is particularly significant due to its potential use as a preventive or therapeutic agent for a wide range of diseases linked to oxidative stress. These include hepatic diseases like non-alcoholic steatohepatitis (NASH), cardiovascular diseases such as heart failure and pulmonary arterial hypertension, and various other conditions affecting the lungs, kidneys, central nervous system, and inflammatory diseases among others. This innovative compound illustrates how Hara's work aims to address pressing health challenges.
Career Highlights: Hara is a key member of Scohia Pharma, Inc., where he contributes to the company’s mission of developing advanced therapeutic solutions. His work reflects a strong commitment to pharmaceutical innovation, particularly in the realm of treatments that target diseases influenced by oxidative stress.
Collaborations: Throughout his career, Ryoma Hara has collaborated with esteemed colleagues, including Shigemitsu Matsumoto and Naoyoshi Noguchi. These partnerships enhance the research and development processes at Scohia Pharma, Inc., fostering a collaborative environment that encourages the advancement of new medical therapies.
Conclusion: Ryoma Hara represents the forefront of scientific innovation, with a patent that underscores the significance of addressing diseases linked to oxidative stress. His work at Scohia Pharma and his collaborations highlight the importance of teamwork in driving medical advancements. As he continues to develop new therapies, Hara’s contributions will undoubtedly play a crucial role in improving health outcomes and enhancing quality of life for many individuals facing serious health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile